Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y C Lin

Showing results (661-670 of 701) with videos related to

Pageof 71
Sort By:
Transplantation|February 7, 2001
Telomerase activity in rat liver allograftsS Goto, Y C Lin, C Y Lai, et al.
Transplantation Proceedings|December 5, 1998
The suppression of heart and liver allograft rejection by liver suppressor factor one (LSF-1) and its possible human homologueS Goto, R Lord, Y Shimizu, et al.
Transplantation Proceedings|December 20, 2000
Expression of clusterin in a rat tolerogenic OLT modelK C Chiang, C L Chen, C L Lin, et al.
American Journal of Surgery|April 10, 2022
Third year medical student knowledge gaps after a virtual surgical rotationSophia Hernandez, Siyou Song, Ogonna N Nnamani Silva, et al.
Studies in Mycology|December 24, 2024
Phylogenetic diversity and morphological characterization of cordycipitaceous species in TaiwanW Y Chuang, Y C Lin, B Shrestha, et al.
Transplantation Proceedings|December 19, 2006
Role of antinuclear antibodies in experimental and clinical liver transplantationT Nakano, C-Y Lai, S Goto, et al.
Transplantation Proceedings|December 19, 2006
Histone H1 vaccine therapy for overcoming acute rejection in experimental organ transplantationT Nakano, K Ono, S Goto, et al.
Oncogene|May 9, 2007
Human p16gamma, a novel transcriptional variant of p16(INK4A), coexpresses with p16(INK4A) in cancer cells and inhibits cell-cycle progressionY-C Lin, M B Diccianni, Y Kim, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Mechanistic Language Modeling and Oxygenated 3D Screening Reveal Berberine and Enzalutamide Synergy in Resistant Prostate CancerChih-Hui Lo, Katie Shi, Lina Kafadarian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2016
Single-agent capecitabine as maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of metastatic colorectal cancer: randomized clinical trial of efficacy and safetyH Y Luo, Y H Li, W Wang, et al.
Pageof 71

Showing results (661-670 of 701) with videos related to

Sort By:
Pageof 71
Transplantation|February 7, 2001
Telomerase activity in rat liver allograftsS Goto, Y C Lin, C Y Lai, et al.
Transplantation Proceedings|December 5, 1998
The suppression of heart and liver allograft rejection by liver suppressor factor one (LSF-1) and its possible human homologueS Goto, R Lord, Y Shimizu, et al.
Transplantation Proceedings|December 20, 2000
Expression of clusterin in a rat tolerogenic OLT modelK C Chiang, C L Chen, C L Lin, et al.
American Journal of Surgery|April 10, 2022
Third year medical student knowledge gaps after a virtual surgical rotationSophia Hernandez, Siyou Song, Ogonna N Nnamani Silva, et al.
Studies in Mycology|December 24, 2024
Phylogenetic diversity and morphological characterization of cordycipitaceous species in TaiwanW Y Chuang, Y C Lin, B Shrestha, et al.
Transplantation Proceedings|December 19, 2006
Role of antinuclear antibodies in experimental and clinical liver transplantationT Nakano, C-Y Lai, S Goto, et al.
Transplantation Proceedings|December 19, 2006
Histone H1 vaccine therapy for overcoming acute rejection in experimental organ transplantationT Nakano, K Ono, S Goto, et al.
Oncogene|May 9, 2007
Human p16gamma, a novel transcriptional variant of p16(INK4A), coexpresses with p16(INK4A) in cancer cells and inhibits cell-cycle progressionY-C Lin, M B Diccianni, Y Kim, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Mechanistic Language Modeling and Oxygenated 3D Screening Reveal Berberine and Enzalutamide Synergy in Resistant Prostate CancerChih-Hui Lo, Katie Shi, Lina Kafadarian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2016
Single-agent capecitabine as maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of metastatic colorectal cancer: randomized clinical trial of efficacy and safetyH Y Luo, Y H Li, W Wang, et al.
Pageof 71